Joshua Aviram

765 total citations
20 papers, 471 citations indexed

About

Joshua Aviram is a scholar working on Pharmacology, Psychiatry and Mental health and Physiology. According to data from OpenAlex, Joshua Aviram has authored 20 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmacology, 7 papers in Psychiatry and Mental health and 5 papers in Physiology. Recurrent topics in Joshua Aviram's work include Cannabis and Cannabinoid Research (11 papers), Musculoskeletal pain and rehabilitation (4 papers) and Pain Mechanisms and Treatments (3 papers). Joshua Aviram is often cited by papers focused on Cannabis and Cannabinoid Research (11 papers), Musculoskeletal pain and rehabilitation (4 papers) and Pain Mechanisms and Treatments (3 papers). Joshua Aviram collaborates with scholars based in Israel and United States. Joshua Aviram's co-authors include Dorit Pud, Elon Eisenberg, Erica Suzan, David Meiri, Gil M. Lewitus, Tamar Shochat, Paula Berman, Roi Treister, Luiza Akria and Gil Bar‐Sela and has published in prestigious journals such as SHILAP Revista de lepidopterología, Pain and Frontiers in Pharmacology.

In The Last Decade

Joshua Aviram

20 papers receiving 460 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joshua Aviram Israel 11 370 121 75 72 66 20 471
Tine van de Donk Netherlands 6 186 0.5× 65 0.5× 48 0.6× 67 0.9× 37 0.6× 6 292
Jack Wilson Australia 10 468 1.3× 36 0.3× 63 0.8× 101 1.4× 110 1.7× 23 657
Mark Montebello Australia 10 386 1.0× 28 0.2× 64 0.9× 114 1.6× 84 1.3× 34 574
Stevie C. Britch United States 8 323 0.9× 77 0.6× 37 0.5× 22 0.3× 46 0.7× 9 415
Justine P. Enns Canada 8 231 0.6× 86 0.7× 53 0.7× 39 0.5× 213 3.2× 9 602
Ryan K. Lanier United States 14 93 0.3× 140 1.2× 59 0.8× 42 0.6× 26 0.4× 29 488
Peter A. Ste‐Marie Canada 16 743 2.0× 98 0.8× 167 2.2× 639 8.9× 104 1.6× 22 983
Craig Sadler Australia 8 230 0.6× 28 0.2× 35 0.5× 60 0.8× 45 0.7× 11 330
Peter Muhleisen Australia 8 196 0.5× 16 0.1× 33 0.4× 47 0.7× 36 0.5× 13 363
Jessica Booth Australia 8 277 0.7× 18 0.1× 48 0.6× 73 1.0× 75 1.1× 10 439

Countries citing papers authored by Joshua Aviram

Since Specialization
Citations

This map shows the geographic impact of Joshua Aviram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joshua Aviram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joshua Aviram more than expected).

Fields of papers citing papers by Joshua Aviram

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joshua Aviram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joshua Aviram. The network helps show where Joshua Aviram may publish in the future.

Co-authorship network of co-authors of Joshua Aviram

This figure shows the co-authorship network connecting the top 25 collaborators of Joshua Aviram. A scholar is included among the top collaborators of Joshua Aviram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joshua Aviram. Joshua Aviram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aviram, Joshua, et al.. (2023). Evaluating Sex Differences in Efficacy, Safety and Pharmacokinetics in Patients Treated with Cannabis by a Metered-Dose Inhaler. Pharmaceuticals. 16(10). 1426–1426. 2 indexed citations
2.
Aviram, Joshua, et al.. (2022). THC degradation does not impair the accuracy of THC doses aerosolized by the metered-dose SyqeAir inhaler: a 24-month stability trial. SHILAP Revista de lepidopterología. 4(1). 55–55. 4 indexed citations
3.
Aviram, Joshua, et al.. (2022). Reply to Montmeat et al.. Pain. 163(12). e1220–e1221. 1 indexed citations
4.
Aviram, Joshua, Gil M. Lewitus, Idan Cohen, et al.. (2022). The Effectiveness and Safety of Medical Cannabis for Treating Cancer Related Symptoms in Oncology Patients. SHILAP Revista de lepidopterología. 3. 861037–861037. 18 indexed citations
5.
Aviram, Joshua, et al.. (2022). Long-term effectiveness and safety of medical cannabis administered through the metered-dose Syqe Inhaler. PAIN Reports. 7(3). e1011–e1011. 5 indexed citations
6.
Pud, Dorit, et al.. (2022). Wellness of patients with chronic pain is not only about pain intensity. Pain Practice. 23(2). 145–154. 5 indexed citations
7.
8.
Aviram, Joshua, et al.. (2021). Sex differences in medical cannabis-related adverse effects. Pain. 163(5). 975–983. 21 indexed citations
9.
Aviram, Joshua, Gil M. Lewitus, Dorit Pud, et al.. (2021). Specific phytocannabinoid compositions are associated with analgesic response and adverse effects in chronic pain patients treated with medical cannabis. Pharmacological Research. 169. 105651–105651. 8 indexed citations
10.
Aviram, Joshua, et al.. (2020). Migraine Frequency Decrease Following Prolonged Medical Cannabis Treatment: A Cross-Sectional Study. Brain Sciences. 10(6). 360–360. 23 indexed citations
11.
Aviram, Joshua, et al.. (2020). Cannabinoid and Terpenoid Doses are Associated with Adult ADHD Status of Medical Cannabis Patients. SHILAP Revista de lepidopterología. 11(1). e0001–e0001. 9 indexed citations
12.
Aviram, Joshua, Gil M. Lewitus, Idan Cohen, et al.. (2020). Short-Term Medical Cannabis Treatment Regimens Produced Beneficial Effects among Palliative Cancer Patients. Pharmaceuticals. 13(12). 435–435. 26 indexed citations
13.
Aviram, Joshua, et al.. (2017). Does self-perception of sensitivity to pain correlate with actual sensitivity to experimental pain?. Journal of Pain Research. Volume 10. 2657–2663. 16 indexed citations
14.
Pud, Dorit, Omar Hameed, Erica Suzan, et al.. (2017). Methylphenidate attenuates the response to cold pain but not to aversive auditory stimuli in healthy human: a double-blind randomized controlled study. PAIN Reports. 2(3). e593–e593. 12 indexed citations
15.
Aviram, Joshua. (2017). Efficacy of Cannabis-Based Medicines for PainManagement: A Systematic Review and MetaAnalysis of Randomized Controlled Trials. Pain Physician. 6(20;6). E755–E796. 202 indexed citations
16.
Eisenberg, Elon, et al.. (2015). Spinal cord stimulation attenuates temporal summation in patients with neuropathic pain. Pain. 156(3). 381–385. 32 indexed citations
17.
Suzan, Erica, Joshua Aviram, Roi Treister, Elon Eisenberg, & Dorit Pud. (2015). Individually based measurement of temporal summation evoked by a noxious tonic heat paradigm. Journal of Pain Research. 8. 409–409. 20 indexed citations
18.
Aviram, Joshua, Tamar Shochat, & Dorit Pud. (2014). Pain Perception in Healthy Young Men Is Modified by Time-Of-Day and Is Modality Dependent. Pain Medicine. 16(6). 1137–1144. 42 indexed citations
19.
Aviram, Joshua, Dorit Pud, & Tamar Shochat. (2013). Pain sensitivity in healthy young men is modified by time-of-day. Sleep Medicine. 14. e265–e265. 3 indexed citations
20.
Shochat, Tamar, Joshua Aviram, & Dorit Pud. (2013). Longer sleep duration is related to increased pain sensitivity in healthy young men. Sleep Medicine. 14. e266–e266. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026